SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA ARTICLE H impact

Flerie secures Swedish approval for Biosergen merger

Swedish Companies Registration Office cleared Flerie's merger with Biosergen, with registration expected on October 23, 2026. Biosergen will dissolve, transferring assets and liabilities to the acquirer; operations will move to a new subsidiary of Flerie Invest. Trading in Biosergen shares on Nasdaq First North Growth Market is expected to end October 22, 2026, ahead of delisting. Shareholders recorded on October 26, 2026, will receive one newly issued ordinary share in the acquirer for every 31 Biosergen shares. Delivery of the merger consideration is expected on or about October 28, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Flerie AB published the original content used to generate this news brief on October 16, 2026, and is solely responsible for the information contained therein. (C)

FLERIE.ST

Swedish Companies Registration Office cleared Flerie's merger with Biosergen, with registration expected on October 23, 2026. Biosergen will dissolve, transferring assets and liabilities to the acquirer; operations will move to a new subsidiary of Flerie Invest. Trading in Biosergen shares on Nasdaq First North Growth Market is expected to end October 22, 2026, ahead of delisting. Shareholders recorded on October 26, 2026, will receive one newly issued ordinary share in the acquirer for every 31 Biosergen shares.

Delivery of the merger consideration is expected on or about October 28, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Flerie AB published the original content used to generate this news brief on October 16, 2026, and is solely responsible for the information contained therein.

(C)